I-ACT for Children Welcomes Gary Noel, MD, as Chief Medical Officer

The Institute for Advanced Clinical Trials (I-ACT) for Children is pleased to announce the appointment of Gary Noel, MD, as its Chief Medical Officer. Dr. Noel is a pediatrician, child advocate, specialist in Infectious Diseases and Immunology and a seasoned expert in drug development, having spent more than 30 years in leadership roles in
the biopharmaceutical industry and academia. He will be joining I-ACT for Children on January 6 after retiring from Johnson & Johnson, where he most recently served as a member of the Child Health Innovation Leadership Department in the Office of the Chief Medical Officer and as chair of its Pediatric Expert Panel.

“With five pharmaceutical members on board and a host of pediatric research projects in our pipeline, our goal was to find a CMO with deep pediatric product development experience, exceptional academic credentials and a passion for improving the therapeutic options available to children,” said I-ACT for Children Chief Executive Officer Laura Gordon. “Dr. Noel brings that unique combination to our organization; he will be critical to our continued growth and to the success of our work.”

Dr. Noel has held various leadership roles at Johnson & Johnson and was previously Vice President and Chief Medical Officer at Paratek Pharmaceuticals and Vice President of early clinical development in Infectious Diseases at AstraZeneca. Prior to his time in industry, Dr. Noel served on the full-time faculty at Cornell University Medical College; was the Chief of Pediatric Infectious Diseases and Immunology at The New York Hospital-Cornell Medical Center; and led the Pediatric Infectious Diseases Fellowship Program and an NIH-funded laboratory. He was the Associate Director of the Cornell University Children’s Clinical Research Center and administrative lead for The New York Hospital’s Program for Children with AIDS.

“Gary is an outstanding leader in pediatric clinical research and brings the interests of children to the forefront of his work,” said Ed Connor, MD, MBE, FAAP, I-ACT for Children’s Chairman of the Board of Directors. “In addition to his scientific and clinical credentials, he has been a leader in the non-profit space, and these attributes make him ideal for this role as a key member of IACT for Children’s leadership team.”

A lifelong champion of pediatric research and care, Dr. Noel helped create the Foundation for Treatment of Children with AIDS (serving as its Executive Director and Board Chair) and played an important role in establishing Pediatric HIV-Comprehensive Medical Care Clinics at The New York Hospital and at the DAR-DAR Project in Dar es Salaam, Tanzania.

He is a fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society and has been a member of the Society for Pediatric Research for more than 30 years. Dr. Noel holds an MD from Cornell and was a Clinical Research Fellow at the Maxwell Finland Laboratory for Infectious Diseases, Boston City Hospital, Boston University School of Medicine.

About I-ACT for Children

I-ACT for Children is an independent 501(c)3 public-private collaboration designed to advance innovative medicines and device development and labeling to improve child health. It serves as a neutral and independent organization on behalf of children everywhere, bringing a dedicated voice to the advancement of new medicines and devices needed now and in the future. I-ACT for Children’s work encompasses both pre-competitive work and projects with
proprietary sponsors.
• Its strategy and planning work ranges from innovative trial design to use of real-world data to enhance the pediatric clinical trial process from the very beginning.
• It has created an infrastructure of pre-qualified sites and works with this network to apply tools and best practices to maximize efficiency.
• I-ACT for Children also plays a thought leadership role, raising awareness of the need to advance medical therapies specifically for children and promoting a sense of urgency to achieve this goal.

To learn more about I-ACT, visit www.iactc.org.